中国当代医药
中国当代医药杂志欢迎您 今天是   2025年4月3日星期四
设为首页  加入收藏  联系我们         
 
      首 页    |    本刊简介     |    期刊荣誉     |    编采团队     |    会务培训     |    理事单位     |    下载专区     |    在线留言     |    联系我们     |     返回中国当代医药网
中国当代医药  2022, Vol. 29 Issue (4): 79-81    
  心血管疾病 本期目录 | 过刊浏览 | 高级检索 |
沙库巴曲缬沙坦治疗盐敏感性高血压的效果分析
任智超 何廉旗 张 建 张思媛
辽宁省抚顺市中心医院心内一科,辽宁抚顺 113006
Effect analysis of Sakobactri Valsartan in the treatment of salt-sensitive hypertension
REN Zhichao HE Lianqi ZHANG Jian ZHANG Siyuan
The First Department of Cardiology, Fushun Central Hospital, Liaoning Province, Fushun 113006, China
全文: PDF (526 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨沙库巴曲缬沙坦治疗盐敏感性高血压(SSH)的效果。方法 选取2020年1月至6月于抚顺市中心医院心内科住院的100 例SSH 患者作为研究对象,采用随机数字表法将其分为对照组与观察组,每组各50例。对照组患者采用缬沙坦胶囊治疗,观察组患者采用沙库巴曲缬沙坦钠片治疗。比较两组患者治疗前后的血压及血管内皮功能指标。结果 治疗后,观察组患者的收缩压(SBP)与舒张压(DBP)水平低于对照组,差异有统计学意义(P<0.05)。治疗后,观察组患者的血清一氧化氮(NO)、降钙素基因相关肽(CGRP)水平高于对照组,内皮素-1(ET-1)水平低于对照组,差异有统计学意义(P<0.05)。结论 沙库巴曲缬沙坦治疗SSH 的效果较好,可有效控制SSH 患者的血压,值得临床推广应用。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
任智超
何廉旗
张 建
张思媛
关键词 盐敏感性高血压沙库巴曲缬沙坦血压血管内皮功能    
Abstract:Objective To investigate the effect of Sakobactri Valsartan on salt-sensitive hypertension (SSH). Methods A total of 100 patients with SSH who were admitted to the Department of Cardiology in Fushun Central Hospital from January to June 2020 were selected as the research objects and divided into the control group and the observation group by random number method, with 50 cases in each group. The patients in the control group were treated with Valsartan Capsules and the patients in the observation group were treated with Sakobactri Valsartan. Blood pressure and vascular endothelial function were compared between the two groups before and after treatment. Results After treatment, the systolic blood pressure (SBP) and diastolic blood pressure (DBP) levels in observation group were lower than those in control group, and the differences were statistically significant (P<0.05). After treatment, the levels of serum nitric oxide (NO) and calcitonin gene-related peptide (CGRP) in the observation group were higher than those in the control group, and the level of endothelin-1 (ET-1) was lower than that in control group, the differences were statistically significant (P<0.05). Conclusion Sakobactril Valsartan has a good effect on the treatment of SSH and can effectively control the blood pressure of SSH patients, which is worthy of clinical application.
Key wordsSalt-sensitive hypertension    Sakobactril Valsartan    Blood pressure value    Vascular endothelial function
    
引用本文:   
任智超;何廉旗;张 建;张思媛. 沙库巴曲缬沙坦治疗盐敏感性高血压的效果分析[J]. 中国当代医药, 2022, 29(4): 79-81.
REN Zhichao;HE Lianqi;ZHANG Jian;ZHANG Siyuan. Effect analysis of Sakobactri Valsartan in the treatment of salt-sensitive hypertension. 中国当代医药, 2022, 29(4): 79-81.
链接本文:  
https://www.dangdaiyiyao.com/CN/     或     https://www.dangdaiyiyao.com/CN/Y2022/V29/I4/79
中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP备11001767号-6  京公网安备 11010502046607号  互联网药品信息服务资格证  期刊出版许可证  广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626690 总机:010-59626692/18/19/20   传真:010-59626204   投稿信箱:ddyy@vip.163.com
地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室   邮编:100124
技术支持:北京玛格泰克科技发展有限公司
Copyright 2000-2014 版权所有 《中国当代医药》杂志社 未经授权请勿转载